Stock Track | Caris Life Sciences Plummets 15.32% Intraday Despite Earnings Beat on Quarterly Loss and Analyst Estimate Revisions

Stock Track05-08

Caris Life Sciences, Inc. (CAI) saw its stock plummet 15.32% in intraday trading on Friday, extending losses from after-hours and pre-market sessions.

The sharp decline followed the company's quarterly earnings release, where it reported breakeven earnings per share, beating analyst expectations of a 2-cent loss, and revenue of $216.17 million, which also exceeded forecasts. However, investor sentiment turned negative as the company reported a quarterly loss of $510 thousand, and market attention focused on significant downward revisions in analyst earnings estimates over the past three months, which fell by approximately 146.6%.

Analyst actions contributed to the pressure, with Piper Sandler reiterating a Hold rating and a $21.00 price target, while Citi lowered its price target on the shares to $28 from $35, though maintaining a Buy rating. The combination of the underlying loss and reduced future expectations drove the sell-off despite the earnings beat.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1138398084?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-08 21:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138398084","market":"hk","top_or_hot":-1,"title":"Stock Track | Caris Life Sciences Plummets 15.32% Intraday Despite Earnings Beat on Quarterly Loss and Analyst Estimate Revisions","media":"Stock Track","content":"<p>Caris Life Sciences, Inc. (CAI) saw its stock plummet 15.32% in intraday trading on Friday, extending losses from after-hours and pre-market sessions.</p><p>The sharp decline followed the company's quarterly earnings release, where it reported breakeven earnings per share, beating analyst expectations of a 2-cent loss, and revenue of $216.17 million, which also exceeded forecasts. However, investor sentiment turned negative as the company reported a quarterly loss of $510 thousand, and market attention focused on significant downward revisions in analyst earnings estimates over the past three months, which fell by approximately 146.6%.</p><p>Analyst actions contributed to the pressure, with Piper Sandler reiterating a Hold rating and a $21.00 price target, while Citi lowered its price target on the shares to $28 from $35, though maintaining a Buy rating. The combination of the underlying loss and reduced future expectations drove the sell-off despite the earnings beat.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Caris Life Sciences Plummets 15.32% Intraday Despite Earnings Beat on Quarterly Loss and Analyst Estimate Revisions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Caris Life Sciences Plummets 15.32% Intraday Despite Earnings Beat on Quarterly Loss and Analyst Estimate Revisions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-08 21:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Caris Life Sciences, Inc. (CAI) saw its stock plummet 15.32% in intraday trading on Friday, extending losses from after-hours and pre-market sessions.</p><p>The sharp decline followed the company's quarterly earnings release, where it reported breakeven earnings per share, beating analyst expectations of a 2-cent loss, and revenue of $216.17 million, which also exceeded forecasts. However, investor sentiment turned negative as the company reported a quarterly loss of $510 thousand, and market attention focused on significant downward revisions in analyst earnings estimates over the past three months, which fell by approximately 146.6%.</p><p>Analyst actions contributed to the pressure, with Piper Sandler reiterating a Hold rating and a $21.00 price target, while Citi lowered its price target on the shares to $28 from $35, though maintaining a Buy rating. The combination of the underlying loss and reduced future expectations drove the sell-off despite the earnings beat.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CAI","symbol_name":"Caris Life Sciences, Inc.","start_time":0,"source_url":"","article_id":"1138398084","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138398084","pubTimestamp":1778247493,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Caris Life Sciences, Inc. (CAI) saw its stock plummet 15.32% in intraday trading on Friday, extending losses from after-hours and pre-market sessions.The sharp decline followed the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CAI":"Caris Life Sciences, Inc."},"translate_title":"个股追踪|Caris Life Sciences盘中暴跌15.32%，尽管财报好于季度亏损和分析师预估修正","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAI":1},"content_text":"Caris Life Sciences, Inc. (CAI) saw its stock plummet 15.32% in intraday trading on Friday, extending losses from after-hours and pre-market sessions.The sharp decline followed the company's quarterly earnings release, where it reported breakeven earnings per share, beating analyst expectations of a 2-cent loss, and revenue of $216.17 million, which also exceeded forecasts. However, investor sentiment turned negative as the company reported a quarterly loss of $510 thousand, and market attention focused on significant downward revisions in analyst earnings estimates over the past three months, which fell by approximately 146.6%.Analyst actions contributed to the pressure, with Piper Sandler reiterating a Hold rating and a $21.00 price target, while Citi lowered its price target on the shares to $28 from $35, though maintaining a Buy rating. The combination of the underlying loss and reduced future expectations drove the sell-off despite the earnings beat.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138398084","isCrawlerRequest":true}